Matt De Silva
North America, California, United States, San Francisco
Description
Matt De Silva is the Chief Operating Officer at Pathos. He was the CEO at Notable Labs
Investor Profile
Matt De Silva has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Seed rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Pharmaceutical, Therapeutics.
Stage Focus
- Series A (67%)
- Seed (33%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Pharmaceutical
- Therapeutics
- Life Science
- Health Care
- Machine Learning
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
